Serum omentin-1 levels are inversely associated with the presence and severity of coronary artery disease in patients with metabolic syndrome

References

• Deng Y, Scherer PE. (2010). Adipokines as novel biomarkers and regulators of the metabolic syndrome. Ann N Y Acad Sci 1212:E1–E19.
   PubMed Web of Science ®Google Scholar
• Eckel RH, Grundy SM, Zimmet PZ. (2005). The metabolic syndrome. Lancet 365:1415–1428.
   PubMed Web of Science ®Google Scholar
• Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F; American Heart Association; National Heart, Lung, and Blood Institute. (2005). Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735–2752.
   PubMed Web of Science ®Google Scholar
• Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP; San Antonio Heart Study. (2004). National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 110:1251–1257.
   PubMed Web of Science ®Google Scholar
• Joint Committee for Developing Chinese guidelines on Prevention and Treatment of Dyslipidemia in Adults. (2007). Zhonghua Xin Xue Guan Bing Za Zhi 35:390–419.
   PubMedGoogle Scholar
• Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. (2002). The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709–2716.
   PubMed Web of Science ®Google Scholar
• Liu R, Wang X, Bu P. (2011). Omentin-1 is associated with carotid atherosclerosis in patients with metabolic syndrome. Diabetes Res Clin Pract 93:21-25.
   Google Scholar
• Mitsutake R, Miura S, Kawamura A, Saku K. (2009). Are metabolic factors associated with coronary artery stenosis on MDCT? Circ J 73:132–138.
   Google Scholar
• Moreno-Navarrete JM, Catalán V, Ortega F, Gómez-Ambrosi J, Ricart W, Frühbeck G, Fernández-Real JM. (2010). Circulating omentin concentration increases after weight loss. Nutr Metab (Lond) 7:27.
   PubMed Web of Science ®Google Scholar
• Moreno-Navarrete JM, Ortega F, Castro A, Sabater M, Ricart W, Fernández-Real JM. (2011). Circulating Omentin as a Novel Biomarker of Endothelial Dysfunction. Obesity (Silver Spring) 19:1552–1559.
   Google Scholar
• Ouchi N, Parker JL, Lugus JJ, Walsh K. (2011). Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11:85–97.
   PubMed Web of Science ®Google Scholar
• Pan HY, Guo L, Li Q. (2010). Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res Clin Pract 88:29–33.
   PubMed Web of Science ®Google Scholar
• Rein P, Saely CH, Beer S, Vonbank A, Drexel H. (2010). Roles of the metabolic syndrome, HDL cholesterol, and coronary atherosclerosis in subclinical inflammation. Diabetes Care 33:1853–1855.
   PubMed Web of Science ®Google Scholar
• Schäffler A, Neumeier M, Herfarth H, Fürst A, Schölmerich J, Büchler C. (2005). Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta 1732:96–102.
   PubMed Web of Science ®Google Scholar
• de Souza Batista CM, Yang RZ, Lee MJ, Glynn NM, Yu DZ, Pray J, Ndubuizu K, Patil S, Schwartz A, Kligman M, Fried SK, Gong DW, Shuldiner AR, Pollin TI, McLenithan JC. (2007). Omentin plasma levels and gene expression are decreased in obesity. Diabetes 56:1655–1661.
   PubMed Web of Science ®Google Scholar
• Tan BK, Pua S, Syed F, Lewandowski KC, O’Hare JP, Randeva HS. (2008). Decreased plasma omentin-1 levels in Type 1 diabetes mellitus. Diabet Med 25:1254–1255.
   PubMed Web of Science ®Google Scholar
• Tatami R, Mabuchi H, Ueda K, Ueda R, Haba T, Kametani T, Ito S, Koizumi J, Ohta M, Miyamoto S, Nakayama A, Kanaya H, Oiwake H, Genda A, Takeda R. (1981). Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease. Circulation 64:1174–1184.
   PubMed Web of Science ®Google Scholar
• Yamawaki H, Tsubaki N, Mukohda M, Okada M, Hara Y. (2010). Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels. Biochem Biophys Res Commun 393:668–672.
   PubMed Web of Science ®Google Scholar
• Yamawaki H, Kuramoto J, Kameshima S, Usui T, Okada M, Hara Y. (2011). Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochem Biophys Res Commun 408:339–343.
   PubMed Web of Science ®Google Scholar
• Yang RZ, Lee MJ, Hu H, Pray J, Wu HB, Hansen BC, Shuldiner AR, Fried SK, McLenithan JC, Gong DW. (2006). Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab 290:E1253–E1261.
   PubMed Web of Science ®Google Scholar